Collegium Pharmaceutical
About:
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.
Website: http://www.collegiumpharma.com
Top Investors: RA Capital Management, Frazier Healthcare Partners, Longitude Capital, Rock Springs Capital, Eventide
Description:
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.
$309M
$500M to $1B
Stoughton, Massachusetts, United States
2002-01-01
info(AT)collegiumpharma.com
Jane Hirsch, Michael T. Heffernan
101-250
2023-02-07
Public
© 2025 bioDAO.ai